Financhill
Sell
23

SSII Quote, Financials, Valuation and Earnings

Last price:
$4.9000
Seasonality move :
-0.01%
Day range:
$4.8000 - $5.2461
52-week range:
$0.3200 - $22.4200
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
41.25x
P/B ratio:
23.82x
Volume:
81.5K
Avg. volume:
380.4K
1-year change:
25.06%
Market cap:
$966.1M
Revenue:
$20.6M
EPS (TTM):
-$0.08

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
SSII
SS Innovations International
-- -- -- -- --
CATX
Perspective Therapeutics
$170.4K -$0.29 -- -55.87% $14.1071
RVP
Retractable Technologies
-- -- -- -- --
VNRX
VolitionRX
$375.7K -$0.05 6.24% -40.63% $2.94
VTAK
Catheter Precision
$310K -$0.20 118.75% -11.57% --
XTNT
Xtant Medical Holdings
$31.4M -$0.02 4.73% -33.33% $1.75
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
SSII
SS Innovations International
$4.9900 -- $966.1M -- $0.00 0% 41.25x
CATX
Perspective Therapeutics
$3.9800 $14.1071 $295.4M -- $0.00 0% 28.05x
RVP
Retractable Technologies
$0.68 -- $20.4M -- $0.00 0% 0.60x
VNRX
VolitionRX
$0.68 $2.94 $70.1M -- $0.00 0% 46.87x
VTAK
Catheter Precision
$0.24 -- $2.6M 0.40x $0.00 0% 2.76x
XTNT
Xtant Medical Holdings
$0.69 $1.75 $95.9M -- $0.00 0% 0.77x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
SSII
SS Innovations International
15.93% 1.564 0.4% 1.59x
CATX
Perspective Therapeutics
-- 1.363 -- --
RVP
Retractable Technologies
1.48% -0.677 12.06% 4.40x
VNRX
VolitionRX
-29.91% 3.387 11.38% 0.34x
VTAK
Catheter Precision
17.75% -1.532 53.57% 0.13x
XTNT
Xtant Medical Holdings
43.24% 1.491 51.14% 0.96x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
SSII
SS Innovations International
$1.1M -$5.9M -48.39% -76.16% -103.53% -$7M
CATX
Perspective Therapeutics
-- -$21.8M -- -- -- -$26.2M
RVP
Retractable Technologies
-$1.9K -$3.2M -25.99% -26.39% -122.86% -$1.6M
VNRX
VolitionRX
-- -$5.4M -- -- -2183.56% -$4.3M
VTAK
Catheter Precision
$132K -$3.5M -126.5% -137.84% -3300.7% -$2.3M
XTNT
Xtant Medical Holdings
$20.2M $1.1M -15.44% -26.62% 3.28% $87K

SS Innovations International vs. Competitors

  • Which has Higher Returns SSII or CATX?

    Perspective Therapeutics has a net margin of -110.95% compared to SS Innovations International's net margin of --. SS Innovations International's return on equity of -76.16% beat Perspective Therapeutics's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    SSII
    SS Innovations International
    21.23% -$0.03 $48.2M
    CATX
    Perspective Therapeutics
    -- -$0.25 --
  • What do Analysts Say About SSII or CATX?

    SS Innovations International has a consensus price target of --, signalling downside risk potential of --. On the other hand Perspective Therapeutics has an analysts' consensus of $14.1071 which suggests that it could grow by 254.45%. Given that Perspective Therapeutics has higher upside potential than SS Innovations International, analysts believe Perspective Therapeutics is more attractive than SS Innovations International.

    Company Buy Ratings Hold Ratings Sell Ratings
    SSII
    SS Innovations International
    0 0 0
    CATX
    Perspective Therapeutics
    10 1 0
  • Is SSII or CATX More Risky?

    SS Innovations International has a beta of -68.829, which suggesting that the stock is 6982.93% less volatile than S&P 500. In comparison Perspective Therapeutics has a beta of 1.177, suggesting its more volatile than the S&P 500 by 17.701%.

  • Which is a Better Dividend Stock SSII or CATX?

    SS Innovations International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SS Innovations International pays -- of its earnings as a dividend. Perspective Therapeutics pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SSII or CATX?

    SS Innovations International quarterly revenues are $5.1M, which are larger than Perspective Therapeutics quarterly revenues of --. SS Innovations International's net income of -$5.7M is higher than Perspective Therapeutics's net income of -$18.2M. Notably, SS Innovations International's price-to-earnings ratio is -- while Perspective Therapeutics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SS Innovations International is 41.25x versus 28.05x for Perspective Therapeutics. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SSII
    SS Innovations International
    41.25x -- $5.1M -$5.7M
    CATX
    Perspective Therapeutics
    28.05x -- -- -$18.2M
  • Which has Higher Returns SSII or RVP?

    Retractable Technologies has a net margin of -110.95% compared to SS Innovations International's net margin of -126.59%. SS Innovations International's return on equity of -76.16% beat Retractable Technologies's return on equity of -26.39%.

    Company Gross Margin Earnings Per Share Invested Capital
    SSII
    SS Innovations International
    21.23% -$0.03 $48.2M
    RVP
    Retractable Technologies
    -0.02% -$0.35 $77.8M
  • What do Analysts Say About SSII or RVP?

    SS Innovations International has a consensus price target of --, signalling downside risk potential of --. On the other hand Retractable Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that SS Innovations International has higher upside potential than Retractable Technologies, analysts believe SS Innovations International is more attractive than Retractable Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    SSII
    SS Innovations International
    0 0 0
    RVP
    Retractable Technologies
    0 0 0
  • Is SSII or RVP More Risky?

    SS Innovations International has a beta of -68.829, which suggesting that the stock is 6982.93% less volatile than S&P 500. In comparison Retractable Technologies has a beta of 1.357, suggesting its more volatile than the S&P 500 by 35.696%.

  • Which is a Better Dividend Stock SSII or RVP?

    SS Innovations International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Retractable Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SS Innovations International pays -- of its earnings as a dividend. Retractable Technologies pays out -1.94% of its earnings as a dividend.

  • Which has Better Financial Ratios SSII or RVP?

    SS Innovations International quarterly revenues are $5.1M, which are smaller than Retractable Technologies quarterly revenues of $8.3M. SS Innovations International's net income of -$5.7M is higher than Retractable Technologies's net income of -$10.5M. Notably, SS Innovations International's price-to-earnings ratio is -- while Retractable Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SS Innovations International is 41.25x versus 0.60x for Retractable Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SSII
    SS Innovations International
    41.25x -- $5.1M -$5.7M
    RVP
    Retractable Technologies
    0.60x -- $8.3M -$10.5M
  • Which has Higher Returns SSII or VNRX?

    VolitionRX has a net margin of -110.95% compared to SS Innovations International's net margin of -2201.34%. SS Innovations International's return on equity of -76.16% beat VolitionRX's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    SSII
    SS Innovations International
    21.23% -$0.03 $48.2M
    VNRX
    VolitionRX
    -- -$0.06 -$22.6M
  • What do Analysts Say About SSII or VNRX?

    SS Innovations International has a consensus price target of --, signalling downside risk potential of --. On the other hand VolitionRX has an analysts' consensus of $2.94 which suggests that it could grow by 332.35%. Given that VolitionRX has higher upside potential than SS Innovations International, analysts believe VolitionRX is more attractive than SS Innovations International.

    Company Buy Ratings Hold Ratings Sell Ratings
    SSII
    SS Innovations International
    0 0 0
    VNRX
    VolitionRX
    3 1 0
  • Is SSII or VNRX More Risky?

    SS Innovations International has a beta of -68.829, which suggesting that the stock is 6982.93% less volatile than S&P 500. In comparison VolitionRX has a beta of 1.198, suggesting its more volatile than the S&P 500 by 19.798%.

  • Which is a Better Dividend Stock SSII or VNRX?

    SS Innovations International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SS Innovations International pays -- of its earnings as a dividend. VolitionRX pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SSII or VNRX?

    SS Innovations International quarterly revenues are $5.1M, which are larger than VolitionRX quarterly revenues of $246.4K. SS Innovations International's net income of -$5.7M is lower than VolitionRX's net income of -$5.4M. Notably, SS Innovations International's price-to-earnings ratio is -- while VolitionRX's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SS Innovations International is 41.25x versus 46.87x for VolitionRX. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SSII
    SS Innovations International
    41.25x -- $5.1M -$5.7M
    VNRX
    VolitionRX
    46.87x -- $246.4K -$5.4M
  • Which has Higher Returns SSII or VTAK?

    Catheter Precision has a net margin of -110.95% compared to SS Innovations International's net margin of -2828.67%. SS Innovations International's return on equity of -76.16% beat Catheter Precision's return on equity of -137.84%.

    Company Gross Margin Earnings Per Share Invested Capital
    SSII
    SS Innovations International
    21.23% -$0.03 $48.2M
    VTAK
    Catheter Precision
    92.31% -$0.36 $9.6M
  • What do Analysts Say About SSII or VTAK?

    SS Innovations International has a consensus price target of --, signalling downside risk potential of --. On the other hand Catheter Precision has an analysts' consensus of -- which suggests that it could grow by 733.33%. Given that Catheter Precision has higher upside potential than SS Innovations International, analysts believe Catheter Precision is more attractive than SS Innovations International.

    Company Buy Ratings Hold Ratings Sell Ratings
    SSII
    SS Innovations International
    0 0 0
    VTAK
    Catheter Precision
    0 0 0
  • Is SSII or VTAK More Risky?

    SS Innovations International has a beta of -68.829, which suggesting that the stock is 6982.93% less volatile than S&P 500. In comparison Catheter Precision has a beta of -0.724, suggesting its less volatile than the S&P 500 by 172.434%.

  • Which is a Better Dividend Stock SSII or VTAK?

    SS Innovations International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SS Innovations International pays -- of its earnings as a dividend. Catheter Precision pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SSII or VTAK?

    SS Innovations International quarterly revenues are $5.1M, which are larger than Catheter Precision quarterly revenues of $143K. SS Innovations International's net income of -$5.7M is lower than Catheter Precision's net income of -$4M. Notably, SS Innovations International's price-to-earnings ratio is -- while Catheter Precision's PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SS Innovations International is 41.25x versus 2.76x for Catheter Precision. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SSII
    SS Innovations International
    41.25x -- $5.1M -$5.7M
    VTAK
    Catheter Precision
    2.76x 0.40x $143K -$4M
  • Which has Higher Returns SSII or XTNT?

    Xtant Medical Holdings has a net margin of -110.95% compared to SS Innovations International's net margin of 0.18%. SS Innovations International's return on equity of -76.16% beat Xtant Medical Holdings's return on equity of -26.62%.

    Company Gross Margin Earnings Per Share Invested Capital
    SSII
    SS Innovations International
    21.23% -$0.03 $48.2M
    XTNT
    Xtant Medical Holdings
    61.52% -- $77.3M
  • What do Analysts Say About SSII or XTNT?

    SS Innovations International has a consensus price target of --, signalling downside risk potential of --. On the other hand Xtant Medical Holdings has an analysts' consensus of $1.75 which suggests that it could grow by 154.18%. Given that Xtant Medical Holdings has higher upside potential than SS Innovations International, analysts believe Xtant Medical Holdings is more attractive than SS Innovations International.

    Company Buy Ratings Hold Ratings Sell Ratings
    SSII
    SS Innovations International
    0 0 0
    XTNT
    Xtant Medical Holdings
    1 0 1
  • Is SSII or XTNT More Risky?

    SS Innovations International has a beta of -68.829, which suggesting that the stock is 6982.93% less volatile than S&P 500. In comparison Xtant Medical Holdings has a beta of -0.139, suggesting its less volatile than the S&P 500 by 113.918%.

  • Which is a Better Dividend Stock SSII or XTNT?

    SS Innovations International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SS Innovations International pays -- of its earnings as a dividend. Xtant Medical Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SSII or XTNT?

    SS Innovations International quarterly revenues are $5.1M, which are smaller than Xtant Medical Holdings quarterly revenues of $32.9M. SS Innovations International's net income of -$5.7M is lower than Xtant Medical Holdings's net income of $58K. Notably, SS Innovations International's price-to-earnings ratio is -- while Xtant Medical Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SS Innovations International is 41.25x versus 0.77x for Xtant Medical Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SSII
    SS Innovations International
    41.25x -- $5.1M -$5.7M
    XTNT
    Xtant Medical Holdings
    0.77x -- $32.9M $58K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will C3.ai Stock Be in 1 Year?
Where Will C3.ai Stock Be in 1 Year?

C3 .ai (NYSE: AI) has been the poster child for “hype versus execution.”…

What Is the Ceiling for IONQ Stock?
What Is the Ceiling for IONQ Stock?

IonQ (NYSE:IONQ) is a quantum computing startup that, like many…

Can FUBO Stock Double?
Can FUBO Stock Double?

TV streaming service Fubo (NYSE:FUBO) has seen incredible returns so…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
58
INKT alert for Jul 12

MiNK Therapeutics [INKT] is up 727.94% over the past day.

Buy
51
NEGG alert for Jul 12

Newegg Commerce [NEGG] is up 74.03% over the past day.

Buy
68
ATRO alert for Jul 12

Astronics [ATRO] is up 16.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock